350 related articles for article (PubMed ID: 35625630)
1. On the Study of Deubiquitinases: Using the Right Tools for the Job.
Caba C; Mohammadzadeh A; Tong Y
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625630
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1.
Guo Y; Liu Q; Mallette E; Caba C; Hou F; Fux J; LaPlante G; Dong A; Zhang Q; Zheng H; Tong Y; Zhang W
J Biol Chem; 2021 Oct; 297(4):101107. PubMed ID: 34425109
[TBL] [Abstract][Full Text] [Related]
3. Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases.
Hewitt CS; Krabill AD; Das C; Flaherty DP
Biochemistry; 2020 Sep; 59(37):3447-3462. PubMed ID: 32865982
[TBL] [Abstract][Full Text] [Related]
4. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition.
Moghadasi SA; Moraes SN; Harris RS
J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708
[TBL] [Abstract][Full Text] [Related]
5. Cell-Permeable Activity-Based Ubiquitin Probes Enable Intracellular Profiling of Human Deubiquitinases.
Gui W; Ott CA; Yang K; Chung JS; Shen S; Zhuang Z
J Am Chem Soc; 2018 Oct; 140(39):12424-12433. PubMed ID: 30240200
[TBL] [Abstract][Full Text] [Related]
6. Yeast Two-Hybrid Analysis for Ubiquitin Variant Inhibitors of Human Deubiquitinases.
Pascoe N; Seetharaman A; Teyra J; Manczyk N; Satori MA; Tjandra D; Makhnevych T; Schwerdtfeger C; Brasher BB; Moffat J; Costanzo M; Boone C; Sicheri F; Sidhu SS
J Mol Biol; 2019 Mar; 431(6):1160-1171. PubMed ID: 30763569
[TBL] [Abstract][Full Text] [Related]
7. A strategy for modulation of enzymes in the ubiquitin system.
Ernst A; Avvakumov G; Tong J; Fan Y; Zhao Y; Alberts P; Persaud A; Walker JR; Neculai AM; Neculai D; Vorobyov A; Garg P; Beatty L; Chan PK; Juang YC; Landry MC; Yeh C; Zeqiraj E; Karamboulas K; Allali-Hassani A; Vedadi M; Tyers M; Moffat J; Sicheri F; Pelletier L; Durocher D; Raught B; Rotin D; Yang J; Moran MF; Dhe-Paganon S; Sidhu SS
Science; 2013 Feb; 339(6119):590-5. PubMed ID: 23287719
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a Potent Deubiquitinase (DUB) Small-Molecule Activity-Based Probe Enables Broad Spectrum DUB Activity Profiling in Living Cells.
Conole D; Cao F; Am Ende CW; Xue L; Kantesaria S; Kang D; Jin J; Owen D; Lohr L; Schenone M; Majmudar JD; Tate EW
Angew Chem Int Ed Engl; 2023 Nov; 62(47):e202311190. PubMed ID: 37779326
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of Ubiquitin-Based Chemical Tools with Unnatural Amino Acids for Selective Detection of Deubiquitinases.
Rut W; Zmudzinski M; Drag M
Methods Mol Biol; 2023; 2591():59-78. PubMed ID: 36350543
[TBL] [Abstract][Full Text] [Related]
10. Chemical biology tools to study Deubiquitinases and Ubl proteases.
Gorka M; Magnussen HM; Kulathu Y
Semin Cell Dev Biol; 2022 Dec; 132():86-96. PubMed ID: 35216867
[TBL] [Abstract][Full Text] [Related]
11. Cell Lysate-Based AlphaLISA Deubiquitinase Assay Platform for Identification of Small Molecule Inhibitors.
Ott CA; Baljinnyam B; Zakharov AV; Jadhav A; Simeonov A; Zhuang Z
ACS Chem Biol; 2017 Sep; 12(9):2399-2407. PubMed ID: 28836754
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for specific inhibition of the deubiquitinase UCHL1.
Grethe C; Schmidt M; Kipka GM; O'Dea R; Gallant K; Janning P; Gersch M
Nat Commun; 2022 Oct; 13(1):5950. PubMed ID: 36216817
[TBL] [Abstract][Full Text] [Related]
13. UL36 Encoded by Marek's Disease Virus Exhibits Linkage-Specific Deubiquitinase Activity.
Lin J; Ai Y; Zhou H; Lv Y; Wang M; Xu J; Yu C; Zhang H; Wang M
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150874
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Deubiquitinase Catalytic State Using a Structure-Based Approach.
Zhang Z; Das C
Methods Mol Biol; 2023; 2591():1-15. PubMed ID: 36350539
[TBL] [Abstract][Full Text] [Related]
15. Chemical and semisynthetic approaches to study and target deubiquitinases.
Gopinath P; Ohayon S; Nawatha M; Brik A
Chem Soc Rev; 2016 Jul; 45(15):4171-98. PubMed ID: 27049734
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.
Zhang W; Bailey-Elkin BA; Knaap RCM; Khare B; Dalebout TJ; Johnson GG; van Kasteren PB; McLeish NJ; Gu J; He W; Kikkert M; Mark BL; Sidhu SS
PLoS Pathog; 2017 May; 13(5):e1006372. PubMed ID: 28542609
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinases (DUBs) and DUB inhibitors: a patent review.
Farshi P; Deshmukh RR; Nwankwo JO; Arkwright RT; Cvek B; Liu J; Dou QP
Expert Opin Ther Pat; 2015; 25(10):1191-1208. PubMed ID: 26077642
[TBL] [Abstract][Full Text] [Related]
18. Targeting deubiquitinases enabled by chemical synthesis of proteins.
Ohayon S; Spasser L; Aharoni A; Brik A
J Am Chem Soc; 2012 Feb; 134(6):3281-9. PubMed ID: 22279964
[TBL] [Abstract][Full Text] [Related]
19. DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases.
Klonisch T; Logue SE; Hombach-Klonisch S; Vriend J
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892185
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein response.
Perry JW; Ahmed M; Chang KO; Donato NJ; Showalter HD; Wobus CE
PLoS Pathog; 2012; 8(7):e1002783. PubMed ID: 22792064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
